Oregon's November approval of Measure 110 decriminalizing drug possession represents a landmark shift in criminal justice and addiction policy, redirecting individuals caught with small amounts of controlled substances from...
Cerebral Inc., a fast-growing mental health and medication management startup based in San Francisco, recently announced it will stop prescribing most controlled substances to...
Opioid addiction has become a significant issue in the United States, with the rural opioid crisis hitting communities particularly hard. According to KFF Health...
Concert Health, a technology-driven behavioral health medical group, recently closed a $42 million Series B funding round. The round was led by Define Ventures,...
Outcomes data has been positioned as both the key to value-based care and the most effective leverage for substance use disorder (SUD) providers when...
EdTheory, a prominent special education and K-12 mental health services provider, is making a significant expansion by entering the center-based ABA therapy space. This...
In recent weeks, several key organizations within the behavioral health and addiction treatment sectors have made important leadership appointments. These moves signal not only...